Tag: ASN Kidney Week

• Taking sodium-glucose cotransporter 2 inhibitors was linked with lower risks of developing cardiovascular disease and kidney failure among patients with type 1 diabetes when using prediction models called the Steno Type 1 Risk Engines.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.

• People who are on dialysis or who have undergone kidney transplantation have immune system–related differences compared with people with normal kidney function, and these differences are further amplified by SARS-CoV-2 infection.
• The findings may help explain why these individuals face a higher risk of dying from COVID-19.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.

• Results from a recent clinical trial indicate that the diabetes drug dapagliflozin slows kidney function decline in patients with chronic kidney disease, regardless of whether they have diabetes.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented online at ASN Kidney Week 2021 November 4–November 7.

• Certain factors may explain why men are more likely than women to develop kidney stones.
• The gap between men and women in terms of risk of stones is getting smaller.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4-November 7.

• Investigators found that the Kidney Disease Risk Equation can predict a patient’s likelihood of developing chronic kidney disease, based on readily available information.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.

• New research indicates that substantial discrepancies exist between eGFR and mGFR, which are different assessments of kidney function, even in an individual patient.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.

• Among hospitalized patients, a diagnosis of acute kidney injury was linked to worse patient outcomes after hospital discharge.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.

• Among adults undergoing cardiac surgery, those who took proton pump inhibitors before surgery were more likely to develop acute kidney injury and to die during hospitalization.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.